NCT01776970View on ClinicalTrials.gov

Safety and Efficacy on Spasticity Symptoms of a Cannabis Sativa Extract in Motor Neuron Disease

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Motor Neuron DiseaseAmyotrophic Lateral Sclerosis (ALS)
Interventions
DRUG

Cannabis Sativa extract Oromucosal spray

Comparison between active drug (Cannabis Sativa extract Oromucosal spray, containing THC (27 mg/ml):CBD (25 mg/ml) vs placebo

Trial Locations (4)

20132

San Raffaele Scientific Institute, Milan

Unknown

Fondazione Salvatore Maugeri IRCCS, Istituto Scientifico, Milan

NEuroMuscular Omnicentre (NEMO), Fondazione Serena - H Cà granda, Milan

Universita' Degli Studi Di Padova, Azienda Ospedaliera Di Padova, Neurologic Department;, Padua

All Listed Sponsors
collaborator

Fondazione Salvatore Maugeri

OTHER

collaborator

Niguarda Hospital

OTHER

collaborator

University of Padova

OTHER

lead

Ospedale San Raffaele

OTHER

NCT01776970 - Safety and Efficacy on Spasticity Symptoms of a Cannabis Sativa Extract in Motor Neuron Disease | Biotech Hunter | Biotech Hunter